MeSH tree: D23.119.960
In a study published in Advanced Materials, a research team developed an innovative bacterial cellulose (BC)-based hemostatic dressing that enables rapid and sustained bleeding control.
Aug 2, 2025
0
58
The U.S. Food and Drug Administration (FDA) approved Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients aged 12 years and older with ...
Oct 15, 2024
0
0
Nature gave ticks, mosquitoes and leeches a quick-acting way to keep blood from clotting while they extract their meal from a host. Now the key to that method has been harnessed by a team of Duke researchers as a potential ...
May 13, 2024
0
56
Researchers at the University of Sydney and University of Geneva have developed a new anticoagulant, whose anticlotting action can be rapidly stopped "on demand." The result could lead to new surgical and post-operative drugs ...
Apr 30, 2024
0
32
The development of a new treatment strategy for bacterial infections and sepsis is being led by researchers at Lund University. In a study published in Nature Communications, the researchers demonstrate how they can neutralize ...
Jan 10, 2024
0
24
Immunothrombosis, or the formation of microscopic blood clots during inflammation, is a major cause of morbidity among patients with sepsis or severe COVID-19. A key enzyme in this process is thrombin. To date, no method ...
Aug 10, 2023
0
1
Hemostasis is vital to prevent excessive blood loss. However, there is an increased risk for thrombosis if there is an excessive reaction and uncontrolled formation of fibrin. In a new study published in Nature Cardiovascular ...
Mar 24, 2023
0
15
